The objective of this provocative conference is to bring together those concerned about drug discovery (academia, industry, biotech, funders, charities, patient groups) to honestly and openly debate the bottlenecks hindering innovation and real tangible results, as perceived by these communities.
The conference will consist of six different discussion panels, each composed by three Panellists and two Chairs. Short talks by the Panellists (15 min each) will be followed by critical and direct questioning by the Chairs, who will also encourage participation from the audience.
We will be focussing on how can the academia, biotechs, charities/ foundations and the industry complement each other and drive drug discovery forward through constructive restructuring of the relationships between the participants.
The conference will consist of six different discussion panels, each composed by three Panellists and two Chairs. Short talks by the Panellists (15 min each) will be followed by critical and direct questioning by the Chairs, who will also encourage participation from the audience.
We will be focussing on how can the academia, biotechs, charities/ foundations and the industry complement each other and drive drug discovery forward through constructive restructuring of the relationships between the participants.
